Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/14676042

Download in:

View as

General Info

PMID
14676042